Volume 28, Number 2 (2002), in the article “Low-Dose N-Butyldeoxynojirimycin (OGT 918) for Type I Gaucher Disease,” by Rene Heitner, Deborah Elstein, Johannes Aerts, Sonja van Weely, and Ari Zimran, pages 127–133 (doi:10.1006/bcmd.2002.0497)

By  

Blood Cells, Molecules, and Diseases, Vol. 28, Iss. 2, 2002-02 ,pp. : 301-301

Academic Press

Access to resources Recommend Favorite

Low-Dose High-Frequency Enzyme Replacement Therapy Prevents Fractures without Complete Suppression of Painful Bone Crises in Patients with Severe Juvenile Onset Type I Gaucher Disease

By Cohen I.J.   Katz K.   Kornreich L.   Horev G.   Frish A.   Beutler R.E.  

Blood Cells, Molecules, and Diseases, Vol. 24, Iss. 3, 1998-09 ,pp. : 296-302

Academic Press

Access to resources Recommend Favorite

Commentary: Low-dose High-frequency Enzyme Replace-ment Therapy Prevents Fractures Without Complete Suppression of Painful Bone Crises in Patients with Severe Juvenile Onset Type I Gaucher Disease

By Elstein D.   Abrahamov A.   Itzchaki M.   Zimran A.  

Blood Cells, Molecules, and Diseases, Vol. 24, Iss. 3, 1998-09 ,pp. : 303-305

Academic Press

Access to resources Recommend Favorite

Comparative Efficacy of Dose Regimens in Enzyme Replacement Therapy of Type I Gaucher Disease

By Altarescu G.   Schiffmann R.   Parker C.C.   Moore D.F.   Kreps C.   Brady R.O.   Barton N.W.  

Blood Cells, Molecules, and Diseases, Vol. 26, Iss. 4, 2000-08 ,pp. : 285-290

Academic Press

Access to resources Recommend Favorite

Gaucher disease type I complicated with Parkinson's syndrome

By Várkonyi Judit   Simon Zsuzsa   Soós Krisztina   Poros Anna  

Haematologia, Vol. 32, Iss. 3, 2002-09 ,pp. : 271-275

VSP

Access to resources Recommend Favorite